









Mercados
/
Ações
/
nasdaq-neo
/

Neogenomics Inc

NEO

10.420USD

+0.020+0.19%

Fechamento 11/11, 16:00（ET）Cotações atrasadas em 15 min

1.34BValor de mercado

PerdaP/L TTM



Neogenomics Inc

10.420

+0.020+0.19%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Neogenomics Inc Empresa

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Informações de Neogenomics Inc



Código da empresaNEO

Nome da EmpresaNeogenomics Inc

Data de listagemDec 10, 2012

CEOMr. Antony P. Zook

Número de funcionários2200

Tipo de títulosOrdinary Share

Fim do ano fiscalDec 10

Endereço9490 Neogenomics Way

CidadeFORT MYERS

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal33912

Telefone12397680600

Sitehttps://neogenomics.com/

Código da empresaNEO

Data de listagemDec 10, 2012

CEOMr. Antony P. Zook

Executivos da empresa Neogenomics Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Dr. Alison L. Hannah, M.D.

Independent Director

Mr. Gregory Aunan

Chief Accounting Officer

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Mr. Michael A. Kelly

Lead Independent Director

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

Sem dados

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

Distribuição de ações

Atualizado em: sex, 31 de out

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

13.73%

The Vanguard Group, Inc.

10.72%

Greenhouse Funds LLLP

5.74%

First Light Asset Management, LLC

5.29%

State Street Investment Management (US)

3.95%

Outro

60.56%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

13.73%

The Vanguard Group, Inc.

10.72%

Greenhouse Funds LLLP

5.74%

First Light Asset Management, LLC

5.29%

State Street Investment Management (US)

3.95%

Outro

60.56%

Tipos de investidores

Investidores

Proporção

Investment Advisor

49.75%

Investment Advisor/Hedge Fund

30.92%

Hedge Fund

13.93%

Research Firm

2.37%

Individual Investor

1.29%

Pension Fund

1.20%

Bank and Trust

0.59%

Sovereign Wealth Fund

0.09%

Family Office

0.05%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

17.77M

13.76%

-516.86K

-2.83%

Jun 30, 2025

The Vanguard Group, Inc.

14.10M

10.92%

-126.36K

-0.89%

Jun 30, 2025

Greenhouse Funds LLLP

7.43M

5.75%

+2.72M

+57.83%

Jun 30, 2025

First Light Asset Management, LLC

6.85M

5.3%

+803.61K

+13.30%

Jun 30, 2025

State Street Investment Management (US)

5.11M

3.96%

+21.77K

+0.43%

Jun 30, 2025

Macquarie Investment Management

4.81M

3.72%

+130.73K

+2.80%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.29M

3.32%

+448.53K

+11.66%

Jun 30, 2025

Schroder Investment Management North America Inc.

3.72M

2.88%

-587.33K

-13.63%

Jun 30, 2025

American Century Investment Management, Inc.

3.52M

2.72%

+197.88K

+5.96%

Jun 30, 2025

Millennium Management LLC

3.32M

2.57%

-3.40M

-50.63%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

SPDR S&P Health Care Services ETF

1.75%

Invesco S&P SmallCap Health Care ETF

0.63%

WisdomTree BioRevolution Fund

0.58%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.4%

Inspire Small/Mid Cap ESG ETF

0.2%

iShares U.S. Healthcare Providers ETF

0.16%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.09%

Nuveen ESG Small-Cap ETF

0.09%

iShares ESG Select Screened S&P Small-Cap ETF

0.08%

SPDR S&P 600 Small Cap Value ETF

0.08%

Ver Mais

SPDR S&P Health Care Services ETF

Proporção1.75%

Invesco S&P SmallCap Health Care ETF

Proporção0.63%

WisdomTree BioRevolution Fund

Proporção0.58%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporção0.4%

Inspire Small/Mid Cap ESG ETF

Proporção0.2%

iShares U.S. Healthcare Providers ETF

Proporção0.16%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

Proporção0.09%

Nuveen ESG Small-Cap ETF

Proporção0.09%

iShares ESG Select Screened S&P Small-Cap ETF

Proporção0.08%

SPDR S&P 600 Small Cap Value ETF

Proporção0.08%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

